Published in J Telemed Telecare on November 15, 2010
Long-running telemedicine networks delivering humanitarian services: experience, performance and scientific output. Bull World Health Organ (2012) 1.37
The Development of a Multilingual Tool for Facilitating the Primary-Specialty Care Interface in Low Resource Settings: the MSF Tele-Expertise System. Front Public Health (2014) 1.34
A web-based telemedicine system for low-resource settings 13 years on: insights from referrers and specialists. Glob Health Action (2013) 1.29
What's Past is Prologue: A Scoping Review of Recent Public Health and Global Health Informatics Literature. Online J Public Health Inform (2015) 1.03
Quality Assurance of Teleconsultations in a Store-and-Forward Telemedicine Network - Obtaining Patient Follow-up Data and User Feedback. Front Public Health (2014) 1.01
Experience with low-cost telemedicine in three different settings. Recommendations based on a proposed framework for network performance evaluation. Glob Health Action (2011) 1.00
The impact of the National HIV Health Care Worker Hotline on patient care in South Africa. AIDS Res Ther (2011) 0.82
User Feedback on the MSF Tele-Expertise Service After a 4-Year Pilot Trial - A Comprehensive Analysis. Front Public Health (2015) 0.80
Teleconsultation and Clinical Decision Making: a Systematic Review. Acta Inform Med (2016) 0.75
Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea. N Engl J Med (2016) 6.22
Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis (2008) 5.94
Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach. Lancet (2011) 5.00
Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis (2010) 4.56
A dimorphic fungus causing disseminated infection in South Africa. N Engl J Med (2013) 4.14
Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy. J Acquir Immune Defic Syndr (2007) 3.78
Marburg hemorrhagic fever associated with multiple genetic lineages of virus. N Engl J Med (2006) 3.38
Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in The Gambia. J Infect Dis (2008) 3.15
Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions. Lancet Infect Dis (2010) 2.86
Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection. PLoS Med (2007) 2.36
Clinical manifestations and case management of Ebola haemorrhagic fever caused by a newly identified virus strain, Bundibugyo, Uganda, 2007-2008. PLoS One (2012) 2.33
Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo. Emerg Infect Dis (2003) 2.22
The impact of HIV care and support interventions on key outcomes in low- and middle-income countries: a literature review--introduction. J Acquir Immune Defic Syndr (2015) 2.19
Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease. Eur J Immunol (2009) 2.16
Autopsy causes of death in HIV-positive individuals in sub-Saharan Africa and correlation with clinical diagnoses. AIDS Rev (2010) 2.09
Combination therapy for visceral leishmaniasis. Lancet Infect Dis (2010) 1.96
Mortality and associated factors after initiation of pediatric antiretroviral treatment in the Democratic Republic of the Congo. Pediatr Infect Dis J (2009) 1.91
Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts. PLoS One (2008) 1.79
Determinants of male involvement in maternal and child health services in sub-Saharan Africa: a review. Reprod Health (2012) 1.75
Antiretroviral preexposure prophylaxis for HIV prevention. N Engl J Med (2013) 1.75
Episodic antiretroviral therapy increases HIV transmission risk compared with continuous therapy: results of a randomized controlled trial. J Acquir Immune Defic Syndr (2008) 1.70
Acceptability of HIV self-testing: a systematic literature review. BMC Public Health (2013) 1.70
Mycobacterium-associated immune reconstitution disease: macrophages running wild? Lancet Infect Dis (2006) 1.68
Knowledge, health seeking behavior and perceived stigma towards tuberculosis among tuberculosis suspects in a rural community in southwest Ethiopia. PLoS One (2010) 1.63
Tuberculosis and HIV co-infection: its impact on quality of life. Health Qual Life Outcomes (2009) 1.62
Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB/HIV patients commencing antiretroviral therapy. J Acquir Immune Defic Syndr (2011) 1.58
ART in low-resource settings: how to do more with less. Lancet (2010) 1.52
Reducing pediatric HIV infection: estimating mother-to-child transmission rates in a program setting in Zambia. J Acquir Immune Defic Syndr (2010) 1.49
Etiology and outcome of fever after a stay in the tropics. Arch Intern Med (2006) 1.47
Predictors of HIV testing among patients with tuberculosis in North West Ethiopia: a case-control study. PLoS One (2010) 1.45
Five-year experience with scaling-up access to antiretroviral treatment in an HIV care programme in Cambodia. Trop Med Int Health (2009) 1.45
Response to 'Does immune reconstitution promote active tuberculosis in patients receiving highly active antiretroviral therapy?' AIDS, 22 July 2005. AIDS (2005) 1.45
Virologic, immunologic, and clinical response to highly active antiretroviral therapy: the gender issue revisited. J Acquir Immune Defic Syndr (2003) 1.44
Treating HIV infection with drugs for HSV-2 infection? Lancet (2010) 1.42
Challenges in HIV and visceral Leishmania co-infection: future research directions. Trop Med Int Health (2010) 1.41
Common mental disorders in TB/HIV co-infected patients in Ethiopia. BMC Infect Dis (2010) 1.41
An algorithm to optimize viral load testing in HIV-positive patients with suspected first-line antiretroviral therapy failure in Cambodia. J Acquir Immune Defic Syndr (2009) 1.40
[Biological and pathological data in a case of yellow fever imported from the Gambia]. Ann Pathol (2005) 1.39
The global epidemiology of bacterial vaginosis: a systematic review. Am J Obstet Gynecol (2013) 1.33
Analysis of two imported cases of yellow fever infection from Ivory Coast and The Gambia to Germany and Belgium. J Clin Virol (2005) 1.33
Implementation of tuberculosis infection control in health facilities in Mukono and Wakiso districts, Uganda. BMC Infect Dis (2013) 1.33
Mobile learning for HIV/AIDS healthcare worker training in resource-limited settings. AIDS Res Ther (2010) 1.31
Sexual risk reduction needs of adolescents living with HIV in a clinical care setting. AIDS Care (2008) 1.30
High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort. BMC Infect Dis (2011) 1.29
Imported non-Plasmodium falciparum malaria: a five-year prospective study in a European referral center. Am J Trop Med Hyg (2006) 1.26
Retention and risk factors for attrition among adults in antiretroviral treatment programmes in Tanzania, Uganda and Zambia. Trop Med Int Health (2014) 1.26
Corticosteroid-modulated immune activation in the tuberculosis immune reconstitution inflammatory syndrome. Am J Respir Crit Care Med (2012) 1.25
Development and evaluation of a clinical algorithm to monitor patients on antiretrovirals in resource-limited settings using adherence, clinical and CD4 cell count criteria. J Int AIDS Soc (2009) 1.25
The spectrum of liver diseases in HIV infected individuals at an HIV treatment clinic in Kampala, Uganda. Afr Health Sci (2008) 1.25
Incidence of treatment-limiting toxicity with stavudine-based antiretroviral therapy in Cambodia: a retrospective cohort study. PLoS One (2012) 1.23
Provider-initiated HIV testing for paediatric inpatients and their caretakers is feasible and acceptable. Trop Med Int Health (2009) 1.23
Corticosteroid therapy, vitamin D status, and inflammatory cytokine profile in the HIV-tuberculosis immune reconstitution inflammatory syndrome. Clin Infect Dis (2012) 1.18
CD4 T-cell count and HIV-1 infection in adults with uncomplicated malaria. J Acquir Immune Defic Syndr (2006) 1.17
An autopsy study describing causes of death and comparing clinico-pathological findings among hospitalized patients in Kampala, Uganda. PLoS One (2012) 1.17
HIV-1 immune suppression and antimalarial treatment outcome in Zambian adults with uncomplicated malaria. J Infect Dis (2006) 1.17
Increased risk for Entamoeba histolytica infection and invasive amebiasis in HIV seropositive men who have sex with men in Taiwan. PLoS Negl Trop Dis (2008) 1.16
Short communication: a cluster of Marburg virus disease involving an infant. Trop Med Int Health (2002) 1.14
Imported Katayama fever: clinical and biological features at presentation and during treatment. J Infect (2005) 1.13
Electronic medical records and same day patient tracing improves clinic efficiency and adherence to appointments in a community based HIV/AIDS care program, in Uganda. AIDS Behav (2012) 1.12
Delays in diagnosis and treatment of pulmonary tuberculosis in Wakiso and Mukono districts, Uganda. BMC Public Health (2014) 1.12
Fever after a stay in the tropics: diagnostic predictors of the leading tropical conditions. Medicine (Baltimore) (2007) 1.11
"It's better not to know": perceived barriers to HIV voluntary counseling and testing among sub-Saharan African migrants in Belgium. AIDS Educ Prev (2009) 1.11
Risk Factors of Active Tuberculosis in People Living with HIV/AIDS in Southwest Ethiopia: A Case Control Study. Ethiop J Health Sci (2011) 1.10
Relatively low primary drug resistant tuberculosis in southwestern Ethiopia. BMC Res Notes (2012) 1.10
Antiretroviral therapy enrollment characteristics and outcomes among HIV-infected adolescents and young adults compared with older adults--seven African countries, 2004-2013. MMWR Morb Mortal Wkly Rep (2014) 1.10
Antiretroviral treatment-associated tuberculosis in a prospective cohort of HIV-infected patients starting ART. Clin Dev Immunol (2010) 1.09
Evaluation of the 2007 WHO guideline to improve the diagnosis of tuberculosis in ambulatory HIV-positive adults. PLoS One (2011) 1.09
Production of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort. PLoS One (2010) 1.09
Do patents prevent access to drugs for HIV in developing countries? JAMA (2002) 1.09
Filovirus hemorrhagic fever outbreak case management: a review of current and future treatment options. J Infect Dis (2011) 1.08
The impact of HIV-1 on the malaria parasite biomass in adults in sub-Saharan Africa contributes to the emergence of antimalarial drug resistance. Malar J (2008) 1.08
Tuberculosis drug resistance testing by molecular methods: opportunities and challenges in resource limited settings. J Microbiol Methods (2010) 1.07
Three-year outcome data of second-line antiretroviral therapy in Ugandan adults: good virological response but high rate of toxicity. J Int Assoc Physicians AIDS Care (Chic) (2008) 1.07
Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine. J Infect Dis (2013) 1.06
Time for "test and treat" in prevention of mother-to-child transmission programs in low- and middle-income countries. J Acquir Immune Defic Syndr (2010) 1.06
Development and validation of systems for rational use of viral load testing in adults receiving first-line ART in sub-Saharan Africa. AIDS (2011) 1.05
Prejudice and misconceptions about tuberculosis and HIV in rural and urban communities in Ethiopia: a challenge for the TB/HIV control program. BMC Public Health (2010) 1.05
Change in quality of life: a follow up study among patients with HIV infection with and without TB in Ethiopia. BMC Public Health (2013) 1.04
Interruption or deferral of antiretroviral therapy reduces markers of bone turnover compared with continuous therapy: The SMART body composition substudy. J Bone Miner Res (2013) 1.03
Antiretroviral drug resistance profiles and response to second-line therapy among HIV type 1-infected Ugandan children. AIDS Res Hum Retroviruses (2013) 1.03
Retention in a NGO supported antiretroviral program in the Democratic Republic of Congo. PLoS One (2012) 1.02
The added value of a CD4 count to identify patients eligible for highly active antiretroviral therapy among HIV-positive adults in Cambodia. J Acquir Immune Defic Syndr (2006) 1.00
The International Index of Erectile Function: development of an adapted tool for use in HIV-positive men who have sex with men. J Sex Med (2009) 1.00
HIV prevalence by race co-varies closely with concurrency and number of sex partners in South Africa. PLoS One (2013) 1.00
Factors associated with carcinoma of the oesophagus at Mulago Hospital, Uganda. Afr Health Sci (2008) 1.00
Identification of probable early-onset biomarkers for tuberculosis disease progression. PLoS One (2011) 1.00
Impact of HIV-1 infection on the hematological recovery after clinical malaria. J Acquir Immune Defic Syndr (2009) 0.99
Infectious mononucleosis-like syndromes in febrile travelers returning from the tropics. J Travel Med (2006) 0.99
Decrease of vitamin D concentration in patients with HIV infection on a non nucleoside reverse transcriptase inhibitor-containing regimen. AIDS Res Ther (2010) 0.99
Strong association between point-concurrency and national peak HIV prevalence. Int J Infect Dis (2012) 0.98
Prevalence of pulmonary TB and spoligotype pattern of Mycobacterium tuberculosis among TB suspects in a rural community in Southwest Ethiopia. BMC Infect Dis (2012) 0.98
Efficient stimulation of HIV-1-specific T cells using dendritic cells electroporated with mRNA encoding autologous HIV-1 Gag and Env proteins. Blood (2005) 0.98
Strategies for optimizing clinic efficiency in a community-based antiretroviral treatment programme in Uganda. AIDS Behav (2013) 0.97
Cross-neutralizing antibodies against primary isolates in African women infected with HIV-1. AIDS (2002) 0.97
Autopsy acceptance rate and reasons for decline in Mulago Hospital, Kampala, Uganda. Trop Med Int Health (2011) 0.96
Adoption of new HIV treatment guidelines and drug substitutions within first-line as a measure of quality of care in rural Lesotho: health centers and hospitals compared. Trop Med Int Health (2012) 0.95
Urinary lipoarabinomannan as predictor for the tuberculosis immune reconstitution inflammatory syndrome. J Acquir Immune Defic Syndr (2011) 0.95
When to switch for antiretroviral treatment failure in resource-limited settings? AIDS (2007) 0.95